跳至主要内容
临床试验/NCT04462458
NCT04462458招募中不适用

Clinical and Radiological Outcomes of M-ARS ACL

Medacta International SA3 个研究点 分布在 2 个国家目标入组 200 人开始时间: 2022年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
3
主要终点
Survival rate

研究概览

简要总结

The goal of this study is to evaluate the performance of Medacta Anatomic Ribbon Surgery (M-ARS) in patients requiring anterior cruciate ligament (ACL) reconstruction.

The main goal is to evaluate the survival rate of M-ARS ACL at 6 months post-operatively. The secondary goals are to assess the survival rate, clinical and functional outcomes, the quality of life, and the rate of complications at 1 month, 1 year and 2 years post-operatively.

详细描述

This s a prospective, multicenter, non-controlled, observational study to evaluate the outcomes of Medacta Anatomic Ribbon Surgery (M-ARS) in the reconstruction of the anterior cruciate ligament (ACL).

Participants will be informed about the study, both orally and in writing, during a preoperative visit. The investigator will answer any questions that may arise and will collect the informed consent. During the study, enrolled participants will be able to withdraw at any time and for any reason.

The study is conducted according to the following schedule:

  • V1 : Inclusion during a preoperative visit
  • V2: Surgery
  • V3: Follow-up visit at 1 month ± 15 days post-surgery
  • V4: Follow-up visit at 6 months ± 30 days post-surgery
  • V5: Follow-up visit at 12 months ± 60 days post-surgery
  • V6: Follow-up visit at 24 months ± 90 days post-surgery

The following data will be collected:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years
  • Patients with ACL rupture requiring ACL reconstruction

排除标准

  • Patients with malignant diseases (at the time of surgery)
  • Patients with proven or suspected infections (at the time of surgery)
  • Patients with functional deficits of the affected extremity (at the time of surgery)
  • Patients with known incompatibility or allergy to products materials (at the time of surgery)

结局指标

主要结局

Survival rate

时间窗: 6 months

Kaplan Meier method

次要结局

  • Functional outcome(1, 6, 12, 24 months)
  • Quality of Life outcome(1, 6, 12, 24 months)
  • Complication rate(intraoperative, 1, 6, 12, 24 months)
  • Survival rate(1, 12, 24 months)
  • Radiological outcome (optional)(1, 6, 12, 24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验